Literature DB >> 27576077

Re-designing the Mozambique vaccine supply chain to improve access to vaccines.

Bruce Y Lee1, Leila A Haidari2, Wendy Prosser3, Diana L Connor4, Ruth Bechtel3, Amelia Dipuve5, Hidayat Kassim6, Balbina Khanlawia7, Shawn T Brown2.   

Abstract

INTRODUCTION: Populations and routine childhood vaccine regimens have changed substantially since supply chains were designed in the 1980s, and introducing new vaccines during the "Decade of Vaccine" may exacerbate existing bottlenecks, further inhibiting the flow of all vaccines.
METHODS: Working with the Mozambique Ministry of Health, our team implemented a new process that integrated HERMES computational simulation modeling and on-the-ground implementers to evaluate and improve the Mozambique vaccine supply chain using a system-re-design that integrated new supply chain structures, information technology, equipment, personnel, and policies.
RESULTS: The alternative system design raised vaccine availability (from 66% to 93% in Gaza; from 76% to 84% in Cabo Delgado) and reduced the logistics cost per dose administered (from $0.53 to $0.32 in Gaza; from $0.38 to $0.24 in Cabo Delgado) as compared to the multi-tiered system under the current EPI. The alternative system also produced higher availability at lower costs after new vaccine introductions. Since reviewing scenarios modeling deliveries every two months in the north of Gaza, the provincial directorate has decided to pilot this approach diverging from decades of policies dictating monthly deliveries. DISCUSSION: Re-design improved not only supply chain efficacy but also efficiency, important since resources to deliver vaccines are limited. The Mozambique experience and process can serve as a model for other countries during the Decade of Vaccines. For the Decade of Vaccines, getting vaccines at affordable prices to the market is not enough. Vaccines must reach the population to be successful.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Computational modeling; Mozambique; Supply chain; Vaccines

Mesh:

Substances:

Year:  2016        PMID: 27576077      PMCID: PMC5547748          DOI: 10.1016/j.vaccine.2016.08.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  The Benin experience: How computational modeling can assist major vaccine policy changes in low and middle income countries.

Authors:  Bruce Y Lee; Benjamin Schreiber; Angela R Wateska; Diana L Connor; Hamadou M Dicko; Philippe Jaillard; Mercy Mvundura; Carol Levin; Mélanie Avella; Leila A Haidari; Shawn T Brown
Journal:  Vaccine       Date:  2015-04-18       Impact factor: 3.641

2.  Digital decision making: computer models and antibiotic prescribing in the twenty-first century.

Authors:  Bruce Y Lee
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

Review 3.  The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making.

Authors:  Bruce Y Lee; Ann E Wiringa
Journal:  Hum Vaccin       Date:  2011-01-01

4.  Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign.

Authors:  Bruce Y Lee; Diana L Connor; Angela R Wateska; Bryan A Norman; Jayant Rajgopal; Brigid E Cakouros; Sheng-I Chen; Erin G Claypool; Leila A Haidari; Veena Karir; Jim Leonard; Leslie E Mueller; Proma Paul; Michelle M Schmitz; Joel S Welling; Yu-Ting Weng; Shawn T Brown
Journal:  Vaccine       Date:  2015-07-23       Impact factor: 3.641

5.  The benefits of redesigning Benin's vaccine supply chain.

Authors:  Shawn T Brown; Benjamin Schreiber; Brigid E Cakouros; Angela R Wateska; Hamadou M Dicko; Diana L Connor; Philippe Jaillard; Mercy Mvundura; Bryan A Norman; Carol Levin; Jayant Rajgopal; Mélanie Avella; Caroline Lebrun; Erin Claypool; Proma Paul; Bruce Y Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

6.  The impact of making vaccines thermostable in Niger's vaccine supply chain.

Authors:  Bruce Y Lee; Brigid E Cakouros; Tina-Marie Assi; Diana L Connor; Joel Welling; Souleymane Kone; Ali Djibo; Angela R Wateska; Lionel Pierre; Shawn T Brown
Journal:  Vaccine       Date:  2012-07-10       Impact factor: 3.641

7.  Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.

Authors:  Tina-Marie Assi; Shawn T Brown; Ali Djibo; Bryan A Norman; Jayant Rajgopal; Joel S Welling; Sheng-I Chen; Rachel R Bailey; Souleymane Kone; Hailu Kenea; Diana L Connor; Angela R Wateska; Anirban Jana; Stephen R Wisniewski; Willem G Van Panhuis; Donald S Burke; Bruce Y Lee
Journal:  BMC Public Health       Date:  2011-06-02       Impact factor: 3.295

8.  Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense.

Authors:  Bruce Y Lee; Brad J Biggerstaff
Journal:  PLoS Med       Date:  2006-01-24       Impact factor: 11.069

9.  Augmenting transport versus increasing cold storage to improve vaccine supply chains.

Authors:  Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Sheng-I Chen; Bruce Y Lee
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  9 in total
  18 in total

Review 1.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

2.  Economic impact of thermostable vaccines.

Authors:  Bruce Y Lee; Patrick T Wedlock; Leila A Haidari; Kate Elder; Julien Potet; Rachel Manring; Diana L Connor; Marie L Spiker; Kimberly Bonner; Arjun Rangarajan; Delphine Hunyh; Shawn T Brown
Journal:  Vaccine       Date:  2017-04-25       Impact factor: 3.641

3.  A two-stage decision-support approach for improving sustainable last-mile cold chain logistics operations of COVID-19 vaccines.

Authors:  Eugenia Ama Andoh; Hao Yu
Journal:  Ann Oper Res       Date:  2022-08-21       Impact factor: 4.820

4.  Using Simulation Modeling to Guide the Design of the Girl Scouts Fierce & Fit Program.

Authors:  Marie C Ferguson; Matthew J Morgan; Kelly J O'Shea; Lucas Winch; Sheryl S Siegmund; Mario Solano Gonzales; Samuel Randall; Daniel L Hertenstein; Valerie Montague; Ayanna Woodberry; Trish Cassatt; Bruce Y Lee
Journal:  Obesity (Silver Spring)       Date:  2020-05-07       Impact factor: 5.002

5.  A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.

Authors:  Sarah N Cox; Patrick T Wedlock; Sarah W Pallas; Elizabeth A Mitgang; Tatenda T Yemeke; Sarah M Bartsch; Taiwo Abimbola; Sheryl S Sigemund; Aaron Wallace; Sachiko Ozawa; Bruce Y Lee
Journal:  Vaccine       Date:  2021-05-25       Impact factor: 3.641

6.  How coping can hide larger systems problems: the routine immunisation supply chain in Bihar, India.

Authors:  Bruce Y Lee; Patrick T Wedlock; Elizabeth A Mitgang; Sarah N Cox; Leila A Haidari; Manoja K Das; Srihari Dutta; Bhrigu Kapuria; Shawn T Brown
Journal:  BMJ Glob Health       Date:  2019-09-05

7.  Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee
Journal:  Vaccine       Date:  2019-03-23       Impact factor: 3.641

8.  A Rapid Cost Modeling Tool for Evaluating and Improving Public Health Supply Chain Designs.

Authors:  Michael Krautmann; Mariam Zameer; Dorothy Thomas; Nora Phillips-White; Ana Costache; Pascale R Leroueil
Journal:  Glob Health Sci Pract       Date:  2020-12-23

9.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

10.  Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Sheryl S Siegmund; Jay DePasse; Jennifer Bakal; Jim Leonard; Joel Welling; Shawn T Brown; Bruce Y Lee
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.